Insight

Health Equity

Doing good and doing well in life sciences

Everyone regardless of identity, ancestry, environment, ability, or skin color, should have a fair and just opportunity to be as healthy as possible.

Achieving health equity requires collaboration across the health ecosystem. It requires a continuous and explicit commitment to focus on those affected by historical disadvantages to improve the health of marginalized groups and eradicate avoidable or remediable differences in health between or among groups of people. KPMG has supported numerous clients at leading health equity strategy development through tactical program execution and is qualified to support organizations on their health equity journey. Read more to learn how we can help your business.

Health Equity
Download PDF

Contact us

Spencer Champagne

Spencer Champagne

Managing Director, Healthcare and Life Sciences Strategy, KPMG US

+1 617-875-5445
Clare Lunn

Clare Lunn

Principal, Advisory, ESG, KPMG US

+1 617-988-1000
Jessica Lin

Jessica Lin

Principal, Healthcare and Life Sciences Strategy, KPMG LLP

+1 212-954-5627
Kristin C. Pothier

Kristin C. Pothier

Global & National, HCLS Deal Advisory & Strategy Leader, KPMG US

+1 617 549 2779
Jeff Stoll, PhD

Jeff Stoll, PhD

Principal, National Strategy Life Sciences Leader, KPMG US

+1 857-334-8768
Christine Kachinsky

Christine Kachinsky

Life Sciences Tax Industry Leader, KPMG US

+1 212-872-2187